Janux Therapeutics Inc. (JANX)
42.78
-0.76 (-1.75%)
At close: Jan 28, 2025, 2:55 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -8.1 | -10.09 | -24.99 | -199.15 | -247 |
| PS Ratio | 58.43 | 63.42 | 223.74 | n/a | n/a |
| PB Ratio | 1.37 | 1.70 | 2.22 | -71.49 | -131.74 |
| P/FCF Ratio | -9.01 | -11.06 | -44.09 | -239.54 | -273.39 |
| P/OCF Ratio | -9.34 | -12.72 | -47.93 | -239.54 | -273.39 |
| OCF/S Ratio | -6.26 | -4.98 | -4.67 | n/a | n/a |
| Debt / Equity Ratio | 0.07 | 0.08 | 0.00 | n/a | -0.5 |
| Quick Ratio | 26.80 | 20.18 | 29.48 | 5.05 | 0.14 |
| Current Ratio | 26.80 | 20.14 | 29.46 | 5.05 | 0.14 |
| Asset Turnover | 0.02 | 0.02 | 0.01 | n/a | n/a |
| Interest Coverage | n/a | -16.64 | n/a | -23.51 | -16.18 |
| Return on Equity (ROE) | -0.17 | -0.17 | -0.09 | 0.36 | 0.53 |
| Return on Assets (ROA) | -0.15 | -0.15 | -0.09 | -0.32 | -6.24 |
| Return on Capital (ROIC) | -0.2 | -0.19 | -0.09 | -0.37 | 0.96 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 75.81% | 90.23% | 96.89% | n/a | n/a |
| Net Profit Margin | -721.18% | -628.82% | -895.22% | n/a | n/a |
| Pretax Profit Margin | -721.18% | -732.22% | -898.32% | n/a | n/a |
| Operating Profit Margin | -902.87% | -779.04% | -905.39% | n/a | n/a |
| FCF Margin | -648.58% | -573.24% | -507.51% | n/a | n/a |
| EBITDA Margin | -878.68% | -769.28% | -902.28% | n/a | n/a |